House-Passed Appropriations Bills Advance Nuclear Medicine Safety, Transparency

Lucerno announced that Fiscal Year 2023 bills passed this week by the U.S. House of Representatives include critical language to improve the safety of nuclear medicine treatments and increase transparency within the American healthcare system. Press Release

Extravasation Reporting Pros and Cons

In 2020 the Health Physics Society (HPS) submitted a public comment, unsupported by science, to the Nuclear Regulatory Commission regarding the reporting of extravasations. In early 2022, the radiation protection journal, Health Physics, provided a forum for discussing the HPS public comment. Lucerno, patients, experts, and HPS members provided written responses to the HPS public comment.

2022 Omnibus Includes Nuclear Medicine Patient Safety, Transparency Provisions

Lucerno announces Fiscal Year 2022 Omnibus Appropriations Act preserves critical language to protect the safety of nuclear medicine patients and enhance transparency within the American healthcare system. Then attach the press release below for full text. Press Release

Nuclear Regulatory Commission’s foot-dragging on patient irradiation suggests regulatory capture

“My analysis shows that the NRC findings predominantly parrot positions of the advisory committee and affiliated societies, such as requiring patients to determine whether a procedure was done correctly; requiring reporting only if a patient experiences permanent functional damage; or taking no action whatsoever.” Full Text

Radiopharmaceutical Extravasations: Interview with
Dr. David W. Townsend

Dr. David W. Townsend, co-founder of the PET/CT scanner, discusses how extravasation affects standardized uptake values and treatment assessment and why extravasations often go undetected. Dr. Townsend believes that monitoring the quality of injection is as important as monitoring all other aspects of the imaging process. Watch full video here

Radiopharmaceutical Extravasations: Interview with
Dr. Marjan Boerma

Dr. Marjan Boerma, radiation biologist and professor at the University of Arkansas for Medical Sciences, discusses radiation injury to tissue and why each individual responds differently to the same dose of radiation. She comments on a specific case in which the patient has received a severe injury to the tissue from radiation, explaining what exactly happened to the cells and what should be done for helping to heal the tissue. Dr. Boerma believes that the patients with significant extravasations should be followed clinically since there is a high chance of long-term effects. Watch full video here

Radiopharmaceutical Extravasations: Interview with
Dr. Jackson Kiser

Dr. Jackson Kiser, Chief of Molecular Imaging Department at Carilion Clinic, explains why complete delivery of the radiopharmaceutical is so important not only for PET/CT studies but for all nuclear medicine procedures. He provides several specific examples from his practice of how extravasation can result in misinterpretation of medical images and affect patient care. Dr. Kiser also shares his opinion on why monitoring extravasations and clinically following extravasated patients will become even more important for the rapidly growing field of radiotherapeutics. Watch full video here

Detection of Excess Presence of 99mTc-MDP Near Injection Site—A Case Report

“This case describes how detection of excess presence of 99mTc-MDP near the injection site enabled the technologist to apply mitigation tactics early in the uptake process. It also suggests that detecting an extravasation or stasis early in the injection process can be important for image interpretation and minimizing radiation dose to tissue.” Full Text

Lucerno Dynamics Announces New Business Relationship with Siemens Healthineers

Lucerno has entered into a Master Resellers Agreement to add its Lara® System to the Siemens Healthineers portfolio of medical imaging products. With this agreement, Siemens Healthineers becomes Lucerno’s first United States partner reseller and makes the Lara® System available to nuclear medicine customers nationwide. Press Release

The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions

“Our findings suggest that significant extravasations can or have caused patient harm and can irradiate patients’ tissue with doses that exceed medical event reporting limits and deterministic effect thresholds. Therefore, diagnostic radiopharmaceutical injections should be monitored, and dosimetry of extravasated tissue should be performed in certain cases where thresholds are thought to have been exceeded. Process improvement efforts should be implemented to reduce the frequency of extravasation in nuclear medicine.” Full Text

Free AltusLearn Webinar

Dr. David Townsend, the co-inventor of PET/CT scanner, Dr. Jackson Kiser, Medical Director of Molecular Imaging at Carilion Clinic, Dr. Darrell Fisher, nuclear medicine physicist, past president Health Physics Society, and previous member of the NRC’s Advisory Committee on the Medical Uses of Isotopes (ACMUI), Dr. Marjan Boerma, the director of the UAMS Division of Radiation Health, and others shared research on extravasations. You can watch the webinar and earn 1 CE credit here.

Radiopharmaceutical Extravasations: Hazards, Mitigation, and Prevention

A panel discussion focusing on how radiopharmaceutical extravasation affects the quality and quantification of nuclear medicine imaging studies. Watch full video here